Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Inter-rater reliability and validity of risk of bias instrument for non-randomized studies of exposures: a study protocol.

Jeyaraman MM, Al-Yousif N, Robson RC, Copstein L, Balijepalli C, Hofer K, Fazeli MS, Ansari MT, Tricco AC, Rabbani R, Abou-Setta AM.

Syst Rev. 2020 Feb 12;9(1):32. doi: 10.1186/s13643-020-01291-z.


Resveratrol for adults with type 2 diabetes mellitus.

Jeyaraman MM, Al-Yousif NSH, Singh Mann A, Dolinsky VW, Rabbani R, Zarychanski R, Abou-Setta AM.

Cochrane Database Syst Rev. 2020 Jan 17;1:CD011919. doi: 10.1002/14651858.CD011919.pub2. Review.


Inter-rater reliability and concurrent validity of ROBINS-I: protocol for a cross-sectional study.

Jeyaraman MM, Rabbani R, Al-Yousif N, Robson RC, Copstein L, Xia J, Pollock M, Mansour S, Ansari MT, Tricco AC, Abou-Setta AM.

Syst Rev. 2020 Jan 13;9(1):12. doi: 10.1186/s13643-020-1271-6.


Dairy product consumption and development of cancer: an overview of reviews.

Jeyaraman MM, Abou-Setta AM, Grant L, Farshidfar F, Copstein L, Lys J, Gottschalk T, Desautels D, Czaykowski P, Pitz M, Zarychanski R.

BMJ Open. 2019 Jan 25;9(1):e023625. doi: 10.1136/bmjopen-2018-023625.


Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: A systematic review and meta-analysis.

Farooqui MA, Elsayed YN, Jeyaraman MM, Dingwall O, Tagin M, Zarychanski R, Rabbani R, Abou-Setta AM.

J Neonatal Perinatal Med. 2019;12(1):1-7. doi: 10.3233/NPM-17130.


Return on investment in healthcare leadership development programs.

Jeyaraman MM, Qadar SMZ, Wierzbowski A, Farshidfar F, Lys J, Dickson G, Grimes K, Phillips LA, Mitchell JI, Van Aerde J, Johnson D, Krupka F, Zarychanski R, Abou-Setta AM.

Leadersh Health Serv (Bradf Engl). 2018 Feb 5;31(1):77-97. doi: 10.1108/LHS-02-2017-0005. Epub 2017 Nov 15. Review.


Autologous Bone Marrow Stem Cell Therapy in Patients With ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.

Jeyaraman MM, Rabbani R, Copstein L, Sulaiman W, Farshidfar F, Kashani HH, Qadar SMZ, Guan Q, Skidmore B, Kardami E, Ducas J, Mansour S, Zarychanski R, Abou-Setta AM.

Can J Cardiol. 2017 Dec;33(12):1611-1623. doi: 10.1016/j.cjca.2017.10.001. Epub 2017 Oct 7. Review.


Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies.

Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, Mann A, Jeyaraman MM, Reid AE, Fiander M, MacKay DS, McGavock J, Wicklow B, Zarychanski R.

CMAJ. 2017 Jul 17;189(28):E929-E939. doi: 10.1503/cmaj.161390. Review.


Erratum to: Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews.

Chauhan BF, Jeyaraman MM, Mann AS, Lys J, Skidmore B, Sibley KM, Abou-Setta AM, Zarychanski R.

Implement Sci. 2017 Mar 17;12(1):38. doi: 10.1186/s13012-017-0568-x. No abstract available.


Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.

Chauhan BF, Jeyaraman MM, Singh Mann A, Lys J, Abou-Setta AM, Zarychanski R, Ducharme FM.

Cochrane Database Syst Rev. 2017 Mar 16;3:CD010347. doi: 10.1002/14651858.CD010347.pub2. Review.


Correction: Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping Review.

Abou-Setta AM, Jeyaraman MM, Attia A, Al-Inany HG, Ferri M, Ansari MT, Garritty CM, Bond K, Norris SL.

PLoS One. 2017 Feb 13;12(2):e0172372. doi: 10.1371/journal.pone.0172372. eCollection 2017.


Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping Review.

Abou-Setta AM, Jeyaraman MM, Attia A, Al-Inany HG, Ferri M, Ansari MT, Garritty CM, Bond K, Norris SL.

PLoS One. 2016 Dec 8;11(12):e0165903. doi: 10.1371/journal.pone.0165903. eCollection 2016. Review. Erratum in: PLoS One. 2017 Feb 13;12 (2):e0172372.


The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis.

Thomas SM, Jeyaraman MM, Hodge WG, Hutnik C, Costella J, Malvankar-Mehta MS.

PLoS One. 2014 Dec 5;9(12):e113779. doi: 10.1371/journal.pone.0113779. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118688. Jeyaraman, Maya [corrected to Jeyaraman, Maya M].


Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor β.

Jeyaraman MM, Fandrich RR, Kardami E.

Front Pharmacol. 2013 Jul 19;4:90. doi: 10.3389/fphar.2013.00090. eCollection 2013.


Connexin43 phosphorylation and cytoprotection in the heart.

Jeyaraman MM, Srisakuldee W, Nickel BE, Kardami E.

Biochim Biophys Acta. 2012 Aug;1818(8):2009-13. doi: 10.1016/j.bbamem.2011.06.023. Epub 2011 Jul 3. Review.


Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state.

Srisakuldee W, Jeyaraman MM, Nickel BE, Tanguy S, Jiang ZS, Kardami E.

Cardiovasc Res. 2009 Sep 1;83(4):672-81. doi: 10.1093/cvr/cvp142. Epub 2009 May 7.


Supplemental Content

Loading ...
Support Center